(IMKTA) Ingles Markets - Overview
Stock: Groceries, Fuel, Pharmacy, Dairy, Organic
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.98% |
| Yield on Cost 5y | 1.34% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 91.6% |
| Payout Ratio | 18.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 25.8% |
| Relative Tail Risk | -5.84% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.95 |
| Alpha | 19.51 |
| Character TTM | |
|---|---|
| Beta | 0.299 |
| Beta Downside | 0.270 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.76% |
| CAGR/Max DD | -0.07 |
Description: IMKTA Ingles Markets January 18, 2026
Ingles Markets, Inc. (NASDAQ: IMKTA) operates a regional supermarket chain under the Ingles and Sav-Mor banners, offering a full suite of grocery items, fresh perishables, pharmacy services, fuel centers, and private-label products. The company also runs a milk-processing plant that supplies organic dairy, juice, and bottled-water brands to external retailers and distributors.
As of the most recent filing, Ingles runs ≈ 210 stores across the Southeast, reporting FY 2023 same-store sales growth of ~ 3.2% and an adjusted EBITDA margin of ~ 7.5%. The firm maintains a modest net-debt-to-EBITDA ratio of ≈ 1.8× and pays a quarterly dividend yielding roughly 2.3%.
Key economic drivers for the grocery sector include inflation-adjusted food price trends, consumer discretionary spending resilience, and fuel price volatility that directly impacts the profitability of the company’s in-store fuel stations. Additionally, the shift toward private-label and locally sourced organic products continues to boost margin expansion for regional grocers like Ingles.
For a deeper quantitative assessment of IMKTA’s valuation and risk profile, you may find ValueRay’s analyst toolkit useful as a next step in your research.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 83.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.50 > 1.0 |
| NWC/Revenue: 12.61% < 20% (prev 10.73%; Δ 1.88% < -1%) |
| CFO/TA 0.06 > 3% & CFO 154.1m > Net Income 83.6m |
| Net Debt (177.4m) to EBITDA (252.5m): 0.70 < 3 |
| Current Ratio: 3.22 > 1.5 & < 3 |
| Outstanding Shares: last quarter (19.0m) vs 12m ago 3.16% < -2% |
| Gross Margin: 23.89% > 18% (prev 0.23%; Δ 2366 % > 0.5%) |
| Asset Turnover: 209.4% > 50% (prev 223.1%; Δ -13.67% > 0%) |
| Interest Coverage Ratio: 6.58 > 6 (EBITDA TTM 252.5m / Interest Expense TTM 19.7m) |
Altman Z'' 5.89
| A: 0.26 (Total Current Assets 975.6m - Total Current Liabilities 302.9m) / Total Assets 2.57b |
| B: 0.63 (Retained Earnings 1.61b / Total Assets 2.57b) |
| C: 0.05 (EBIT TTM 129.6m / Avg Total Assets 2.55b) |
| D: 1.70 (Book Value of Equity 1.62b / Total Liabilities 950.1m) |
| Altman-Z'' Score: 5.89 = AAA |
Beneish M -2.75
| DSRI: 1.44 (Receivables 106.4m/78.3m, Revenue 5.33b/5.64b) |
| GMI: 0.96 (GM 23.89% / 23.05%) |
| AQI: 1.02 (AQ_t 0.02 / AQ_t-1 0.02) |
| SGI: 0.95 (Revenue 5.33b / 5.64b) |
| TATA: -0.03 (NI 83.6m - CFO 154.1m) / TA 2.57b) |
| Beneish M-Score: -2.75 (Cap -4..+1) = A |
What is the price of IMKTA shares?
Over the past week, the price has changed by +13.41%, over one month by +22.96%, over three months by +16.60% and over the past year by +28.98%.
Is IMKTA a buy, sell or hold?
What are the forecasts/targets for the IMKTA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 89.4 | 5.2% |
IMKTA Fundamental Data Overview February 02, 2026
P/E Forward = 9.0253
P/S = 0.2666
P/B = 0.8799
P/EG = 0.8851
Revenue TTM = 5.33b USD
EBIT TTM = 129.6m USD
EBITDA TTM = 252.5m USD
Long Term Debt = 497.3m USD (from longTermDebt, last quarter)
Short Term Debt = 23.2m USD (from shortTermDebt, last quarter)
Debt = 543.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 177.4m USD (from netDebt column, last quarter)
Enterprise Value = 1.60b USD (1.42b + Debt 543.7m - CCE 366.2m)
Interest Coverage Ratio = 6.58 (Ebit TTM 129.6m / Interest Expense TTM 19.7m)
EV/FCF = 40.39x (Enterprise Value 1.60b / FCF TTM 39.6m)
FCF Yield = 2.48% (FCF TTM 39.6m / Enterprise Value 1.60b)
FCF Margin = 0.74% (FCF TTM 39.6m / Revenue TTM 5.33b)
Net Margin = 1.57% (Net Income TTM 83.6m / Revenue TTM 5.33b)
Gross Margin = 23.89% ((Revenue TTM 5.33b - Cost of Revenue TTM 4.06b) / Revenue TTM)
Gross Margin QoQ = 24.46% (prev 24.31%)
Tobins Q-Ratio = 0.62 (Enterprise Value 1.60b / Total Assets 2.57b)
Interest Expense / Debt = 0.91% (Interest Expense 4.96m / Debt 543.7m)
Taxrate = 22.64% (7.52m / 33.2m)
NOPAT = 100.3m (EBIT 129.6m * (1 - 22.64%))
Current Ratio = 3.22 (Total Current Assets 975.6m / Total Current Liabilities 302.9m)
Debt / Equity = 0.34 (Debt 543.7m / totalStockholderEquity, last quarter 1.62b)
Debt / EBITDA = 0.70 (Net Debt 177.4m / EBITDA 252.5m)
Debt / FCF = 4.48 (Net Debt 177.4m / FCF TTM 39.6m)
Total Stockholder Equity = 1.59b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.28% (Net Income 83.6m / Total Assets 2.57b)
RoE = 5.27% (Net Income TTM 83.6m / Total Stockholder Equity 1.59b)
RoCE = 6.22% (EBIT 129.6m / Capital Employed (Equity 1.59b + L.T.Debt 497.3m))
RoIC = 4.76% (NOPAT 100.3m / Invested Capital 2.11b)
WACC = 5.27% (E(1.42b)/V(1.97b) * Re(7.02%) + D(543.7m)/V(1.97b) * Rd(0.91%) * (1-Tc(0.23)))
Discount Rate = 7.02% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈44.4m ; Y1≈29.2m ; Y5≈13.3m
Fair Price DCF = 16.94 (EV 423.9m - Net Debt 177.4m = Equity 246.5m / Shares 14.5m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -78.63 | EPS CAGR: -48.17% | SUE: N/A | # QB: 0
Revenue Correlation: -45.14 | Revenue CAGR: -0.45% | SUE: 4.0 | # QB: 6